AMINOV EREZ (Chief Executive Officer) sold 8.6% of their position (100K shares) of MIRA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $133.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/27/2024ACC: 0001493152-24-047998
DirectorOfficer· Chief Executive Officer
Since Aug 2023
-100K
Net shares
Net seller
$133.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
100K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−55.41K
Price / share
$1.39
Trade value
$77.02K
% of position
4.8%
11/19/2024
1.16M→1.11M
Common Stock
Direct
Shares
−44.59K
Price / share
$1.27
Trade value
$56.63K
% of position
4.0%
11/20/2024
1.11M→1.06M
Total
Net shares
−100K
Net value
-$133.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/19/2024 | S · Sale | −55.41K | $1.39 | $77.02K | 4.8% | 1.16M | 1.11M |
| Common Stock Direct | 11/20/2024 | S · Sale | −44.59K | $1.27 | $56.63K | 4.0% | 1.11M | 1.06M |
| Total | −100K | -$133.65K | ||||||
Derivative Transactions0
No derivative transactions reported